PK Stock Recent News
PK LATEST HEADLINES
The Large Cap Value and Ben Graham Formula strategies identify undervalued, stable stocks with strong fundamentals and low valuations, ideal for long-term investment. Analysts project significant gains (28.24% to 85.64%) from top-ten GASV Dogs by March 2026, based on dividend yields and target prices. Thirteen of nineteen "safer" GASV Dogs are recommended buys, offering reliable dividends and fair pricing relative to their intrinsic value.
TYSONS, Va.--(BUSINESS WIRE)---- $PK #earnings--Park Hotels & Resorts Inc. (NYSE: PK) (“Park”) today announced that it will release its financial results for the first quarter 2025 before the stock market opens on Monday, May 5, 2025. Park will hold a conference call at 10:00 a.m. Eastern Time (ET) that same morning to discuss its earnings results, current operational environment and business outlook. The conference call will be accessible by telephone and through the internet. Interested individuals are inv.
REITs are highly attractive now due to stable or falling interest rates and low inflation, with many offering strong yields while being undervalued. This article identifies 27 REITs yielding at least 75 basis points above the no-risk rate on Treasuries, while selling at discounts of 20% or greater to their Target Fair Value. The list is then screened for dividend safety, to eliminate sucker yields, and for stable revenues, excluding those with flat or declining FFO/share.
Park Hotels & Resorts Inc. (NYSE:PK ) Q4 2024 Earnings Conference Call February 20, 2025 11:00 AM ET Company Participants Ian Weissman - SVP, Corporate Strategy Tom Baltimore - Chairman & CEO Sean Dell'Orto - CFO Conference Call Participants Floris Van Dijkum - Compass Point Duane Pfennigwerth - Evercore ISI David Katz - Jefferies Smedes Rose - Citibank Chris Woronka - Deutsche Bank Chris Darling - Green Street Patrick Scholes - Truist Securities Jay Kornreich - Wedbush Securities Robin Farley - UBS Dori Kesten - Wells Fargo David Hargreaves - Barclays Aryeh Klein - BMO Capital Markets Operator Greetings and welcome to the Park Hotels and Resorts Fourth Quarter and Full Year 2024 Earnings Conference Call. At this time, all participants are in a listen-only mode.
The headline numbers for Park Hotels & Resorts (PK) give insight into how the company performed in the quarter ended December 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Park Hotels & Resorts (PK) came out with quarterly funds from operations (FFO) of $0.39 per share, missing the Zacks Consensus Estimate of $0.40 per share. This compares to FFO of $0.52 per share a year ago.
Before January 31, 2025, my REaders mentioned 40 equities in their comments on my articles. Some bad-news investments (ROgues) mixed with (mostly) FAvorites. Thus, readers spoke-up about the ReFa/Ro. Ten analyst-target-estimated TOP-NET-GAIN ReFa/Ro: CAG, VZ, DOW, PFE, MRK GOGL, PK, PBR FRO, and TRMD averaged 40.36% net gains from reader data collected 2/17/25. Ten analysts target-augured January TOP-PRICE-UPSIDE reader faves & rogues (ReFa/Ro) were: CAG, VZ, PBR, DOW, PFE, GOGL, TRMD, PK, MRK, & FRO, boasting a 27.91% average target price upside estimate.
TYSONS, Va.--(BUSINESS WIRE)---- $PK #earnings--Park Hotels & Resorts Inc. (“Park” or the “Company”) (NYSE: PK) today announced results for the fourth quarter and full-year ended December 31, 2024 and provided an operational update. Selected Statistical and Financial Information (unaudited, amounts in millions, except RevPAR, ADR, Total RevPAR and per share data) Three Months Ended December 31, Year Ended December 31, 2024 2023 Change(1) 2024 2023 Change(1) Comparable RevPAR(2.
Besides Wall Street's top -and-bottom-line estimates for Park Hotels & Resorts (PK), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended December 2024.
– ACTIVATE-Kids is the First Study to Demonstrate Efficacy of an Oral Therapy for Children with PK Deficiency Who Are Not Regularly Transfused –